MEB 12.5% 0.9¢ medibio limited

Ann: Investor Presentation - February 2019, page-33

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 546 Posts.
    lightbulb Created with Sketch. 5
    Monster,

    Really, mate, get a grip. This mob is going nowhere. The company failed to get the clinical trial to show meaningful benefit (ie it failed completely). They bet the house on commercial unregulated “stress”’ management and no one wants it. Most of the directors are doing nothing for the company. The raising is clearly failing (extended deadline, second party company ringing around begging for funds and the share price under the raising price). They could not even get their expected spending graph right (out by $1m over next year).

    The ship is sinking and the couple of lifeboats have holes.

    This has been a needless unmitigated disaster made out of such a promising technology and initial research. I feel very badly for the original inventors who have seen their work so debased.

    They will vend in another tech/play in the near future as this is going to be a shell again very soon.
 
watchlist Created with Sketch. Add MEB (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.